Curative treatment for pancreatic neoplasms: Standard resection

H. A. Pitt

Research output: Contribution to journalArticle

Abstract

In the mid-1990s pancreatoduodenectomy can be performed at regional referral centers with an operative mortality of 1% to 2%. In addition, a number of centers around the world are now reporting 5-year survivals between 20% and 30% for patients with resected pancreatic cancer. In recent years a debate has continued as to the proper extent of resection for these patients, in part because numerous resective and reconstructive options are available. In broad terms, operations can be categorized as 'standard' or 'radical.' In general, standard operations tend to have lower postoperative morbidity and mortality. Multiple factors influence postoperative survival, including intraoperative blood loss, perioperative transfusions, type of operation, hospital mortality, tumor biology, and adjuvant therapy. Among these parameters, tumor biology is the most important by multivariate analysis. Recent data suggest that the quality of survival is better with standard operations and best with the pylorus-preserving pancreatoduodenectomy. Nevertheless, debate will continue about the proper extent of resection until a well-controlled randomized trial has addressed this issue.

Original languageEnglish (US)
Pages (from-to)891-904
Number of pages14
JournalThe Surgical clinics of North America
Volume75
Issue number5
StatePublished - 1995

Fingerprint

Pancreatic Neoplasms
Pancreaticoduodenectomy
Survival
Mortality
Pylorus
Hospital Mortality
Neoplasms
Therapeutics
Referral and Consultation
Multivariate Analysis
Randomized Controlled Trials
Morbidity

ASJC Scopus subject areas

  • Surgery

Cite this

Curative treatment for pancreatic neoplasms : Standard resection. / Pitt, H. A.

In: The Surgical clinics of North America, Vol. 75, No. 5, 1995, p. 891-904.

Research output: Contribution to journalArticle

@article{76c564623da0436abac5a9dc89498227,
title = "Curative treatment for pancreatic neoplasms: Standard resection",
abstract = "In the mid-1990s pancreatoduodenectomy can be performed at regional referral centers with an operative mortality of 1{\%} to 2{\%}. In addition, a number of centers around the world are now reporting 5-year survivals between 20{\%} and 30{\%} for patients with resected pancreatic cancer. In recent years a debate has continued as to the proper extent of resection for these patients, in part because numerous resective and reconstructive options are available. In broad terms, operations can be categorized as 'standard' or 'radical.' In general, standard operations tend to have lower postoperative morbidity and mortality. Multiple factors influence postoperative survival, including intraoperative blood loss, perioperative transfusions, type of operation, hospital mortality, tumor biology, and adjuvant therapy. Among these parameters, tumor biology is the most important by multivariate analysis. Recent data suggest that the quality of survival is better with standard operations and best with the pylorus-preserving pancreatoduodenectomy. Nevertheless, debate will continue about the proper extent of resection until a well-controlled randomized trial has addressed this issue.",
author = "Pitt, {H. A.}",
year = "1995",
language = "English (US)",
volume = "75",
pages = "891--904",
journal = "Surgical Clinics of North America",
issn = "0039-6109",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Curative treatment for pancreatic neoplasms

T2 - Standard resection

AU - Pitt, H. A.

PY - 1995

Y1 - 1995

N2 - In the mid-1990s pancreatoduodenectomy can be performed at regional referral centers with an operative mortality of 1% to 2%. In addition, a number of centers around the world are now reporting 5-year survivals between 20% and 30% for patients with resected pancreatic cancer. In recent years a debate has continued as to the proper extent of resection for these patients, in part because numerous resective and reconstructive options are available. In broad terms, operations can be categorized as 'standard' or 'radical.' In general, standard operations tend to have lower postoperative morbidity and mortality. Multiple factors influence postoperative survival, including intraoperative blood loss, perioperative transfusions, type of operation, hospital mortality, tumor biology, and adjuvant therapy. Among these parameters, tumor biology is the most important by multivariate analysis. Recent data suggest that the quality of survival is better with standard operations and best with the pylorus-preserving pancreatoduodenectomy. Nevertheless, debate will continue about the proper extent of resection until a well-controlled randomized trial has addressed this issue.

AB - In the mid-1990s pancreatoduodenectomy can be performed at regional referral centers with an operative mortality of 1% to 2%. In addition, a number of centers around the world are now reporting 5-year survivals between 20% and 30% for patients with resected pancreatic cancer. In recent years a debate has continued as to the proper extent of resection for these patients, in part because numerous resective and reconstructive options are available. In broad terms, operations can be categorized as 'standard' or 'radical.' In general, standard operations tend to have lower postoperative morbidity and mortality. Multiple factors influence postoperative survival, including intraoperative blood loss, perioperative transfusions, type of operation, hospital mortality, tumor biology, and adjuvant therapy. Among these parameters, tumor biology is the most important by multivariate analysis. Recent data suggest that the quality of survival is better with standard operations and best with the pylorus-preserving pancreatoduodenectomy. Nevertheless, debate will continue about the proper extent of resection until a well-controlled randomized trial has addressed this issue.

UR - http://www.scopus.com/inward/record.url?scp=0029144405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029144405&partnerID=8YFLogxK

M3 - Article

C2 - 7660252

AN - SCOPUS:0029144405

VL - 75

SP - 891

EP - 904

JO - Surgical Clinics of North America

JF - Surgical Clinics of North America

SN - 0039-6109

IS - 5

ER -